vs

Side-by-side financial comparison of Solo Brands, Inc. (SBDS) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $94.0M, roughly 1.4× Solo Brands, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -34.5%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 5.0%).

Conagra Brands, Inc. is an American consumer packaged goods holding company that makes and sells products under various brand names that are available in supermarkets, restaurants, and food service establishments. Based on its 2021 revenue, the company ranked 331st on the 2022 Fortune 500. Headquartered in Chicago, Illinois, Conagra was founded in Nebraska in 1919 and was originally called Nebraska Consolidated Mills.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

SBDS vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.4× larger
ZLAB
$127.1M
$94.0M
SBDS
Growing faster (revenue YoY)
ZLAB
ZLAB
+51.6% gap
ZLAB
17.1%
-34.5%
SBDS
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
5.0%
SBDS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SBDS
SBDS
ZLAB
ZLAB
Revenue
$94.0M
$127.1M
Net Profit
$-83.2M
Gross Margin
60.6%
51.0%
Operating Margin
-81.7%
-54.6%
Net Margin
-88.4%
Revenue YoY
-34.5%
17.1%
Net Profit YoY
-42.9%
EPS (diluted)
$-45.73
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$94.0M
$127.1M
Q3 25
$53.0M
$115.4M
Q2 25
$92.3M
$109.1M
Q1 25
$77.3M
$105.7M
Q4 24
$143.5M
$108.5M
Q3 24
$94.1M
$101.8M
Q2 24
$131.6M
$100.1M
Q1 24
$85.3M
$87.1M
Net Profit
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$-83.2M
Q3 25
$-22.9M
$-36.0M
Q2 25
$-20.8M
$-40.7M
Q1 25
$-18.6M
$-48.4M
Q4 24
$-58.2M
Q3 24
$-111.5M
$-41.7M
Q2 24
$-4.0M
$-80.3M
Q1 24
$-6.5M
$-53.5M
Gross Margin
SBDS
SBDS
ZLAB
ZLAB
Q4 25
60.6%
51.0%
Q3 25
60.0%
59.5%
Q2 25
61.3%
60.6%
Q1 25
55.2%
63.6%
Q4 24
61.1%
61.5%
Q3 24
41.8%
64.1%
Q2 24
62.8%
64.9%
Q1 24
59.2%
61.4%
Operating Margin
SBDS
SBDS
ZLAB
ZLAB
Q4 25
-81.7%
-54.6%
Q3 25
-30.5%
-42.3%
Q2 25
-10.7%
-50.3%
Q1 25
-13.8%
-53.3%
Q4 24
-38.5%
-62.6%
Q3 24
-122.5%
-66.6%
Q2 24
1.7%
-76.0%
Q1 24
-7.4%
-80.7%
Net Margin
SBDS
SBDS
ZLAB
ZLAB
Q4 25
-88.4%
Q3 25
-43.2%
-31.2%
Q2 25
-22.5%
-37.3%
Q1 25
-24.0%
-45.8%
Q4 24
-40.6%
Q3 24
-118.4%
-40.9%
Q2 24
-3.1%
-80.2%
Q1 24
-7.6%
-61.4%
EPS (diluted)
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$-45.73
$-0.05
Q3 25
$-9.22
$-0.03
Q2 25
$-8.93
$-0.04
Q1 25
$-0.21
$-0.04
Q4 24
$-27.74
$-0.09
Q3 24
$-47.72
$-0.04
Q2 24
$-2.14
$-0.08
Q1 24
$-0.06
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SBDS
SBDS
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$20.0M
$689.6M
Total DebtLower is stronger
$242.1M
Stockholders' EquityBook value
$46.0M
$715.5M
Total Assets
$360.3M
$1.2B
Debt / EquityLower = less leverage
5.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$20.0M
$689.6M
Q3 25
$16.3M
$717.2M
Q2 25
$18.1M
$732.2M
Q1 25
$206.4M
$757.3M
Q4 24
$12.0M
$779.7M
Q3 24
$12.5M
$616.1M
Q2 24
$20.1M
$630.0M
Q1 24
$15.4M
$650.8M
Total Debt
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$242.1M
Q3 25
$235.2M
Q2 25
$238.4M
Q1 25
$427.9M
Q4 24
$150.7M
Q3 24
$161.1M
Q2 24
$162.2M
Q1 24
$170.2M
Stockholders' Equity
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$46.0M
$715.5M
Q3 25
$99.1M
$759.9M
Q2 25
$113.2M
$791.7M
Q1 25
$121.7M
$810.8M
Q4 24
$133.7M
$840.9M
Q3 24
$168.0M
$667.7M
Q2 24
$236.7M
$704.2M
Q1 24
$238.5M
$762.2M
Total Assets
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$360.3M
$1.2B
Q3 25
$431.0M
$1.2B
Q2 25
$459.7M
$1.2B
Q1 25
$692.4M
$1.2B
Q4 24
$495.1M
$1.2B
Q3 24
$553.2M
$985.3M
Q2 24
$642.0M
$987.4M
Q1 24
$648.3M
$988.4M
Debt / Equity
SBDS
SBDS
ZLAB
ZLAB
Q4 25
5.26×
Q3 25
2.37×
Q2 25
2.11×
Q1 25
3.52×
Q4 24
1.13×
Q3 24
0.96×
Q2 24
0.69×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SBDS
SBDS
ZLAB
ZLAB
Operating Cash FlowLast quarter
$6.4M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$6.4M
$-26.0M
Q3 25
$11.2M
$-32.0M
Q2 25
$10.9M
$-31.0M
Q1 25
$-75.2M
$-61.7M
Q4 24
$13.0M
$-55.8M
Q3 24
$378.0K
$-26.8M
Q2 24
$15.7M
$-42.2M
Q1 24
$-18.5M
$-90.1M
Free Cash Flow
SBDS
SBDS
ZLAB
ZLAB
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-78.4M
$-63.2M
Q4 24
$9.0M
$-58.4M
Q3 24
$-5.9M
$-28.2M
Q2 24
$12.8M
$-42.9M
Q1 24
$-20.9M
$-91.1M
FCF Margin
SBDS
SBDS
ZLAB
ZLAB
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-101.5%
-59.9%
Q4 24
6.3%
-53.8%
Q3 24
-6.3%
-27.7%
Q2 24
9.8%
-42.9%
Q1 24
-24.5%
-104.5%
Capex Intensity
SBDS
SBDS
ZLAB
ZLAB
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
4.2%
1.5%
Q4 24
2.8%
2.4%
Q3 24
6.7%
1.3%
Q2 24
2.2%
0.7%
Q1 24
2.8%
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SBDS
SBDS

Sales Channel Directly To Consumer$65.4M70%
Sales Channel Through Intermediary$28.6M30%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons